Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Report 2023

Report ID: 865892 | Published Date: Jan 2025 | No. of Page: 139 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview
    1.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Scope
    1.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Type
        1.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016 & 2021 & 2027)
        1.2.2 Serum Biomarkers
        1.2.3 Cytokeratin-18 (CK 18) Marker
        1.2.4 Inflammatory Markers
        1.2.5 Others
    1.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Application
        1.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Hospitals
        1.3.3 Diagnostic Centers
        1.3.4 Others
    1.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Trends (2016-2027)

2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Forecasts by Region
    2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2016-2021)
        2.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2016-2021)
    2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
        2.4.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
        2.4.3 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
        2.4.4 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
        2.4.6 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Competition Landscape by Players
    3.1 Global Top Non-alcoholic Steatohepatitis (NASH) Biomarkers Players by Sales (2016-2021)
    3.2 Global Top Non-alcoholic Steatohepatitis (NASH) Biomarkers Players by Revenue (2016-2021)
    3.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers as of 2020)
    3.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price by Company (2016-2021)
    3.5 Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Type
    4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Historic Market Review by Type (2016-2021)
        4.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
        4.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2016-2021)
        4.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Type (2016-2021)
    4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Type (2022-2027)
        4.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Type (2022-2027)
        4.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Forecast by Type (2022-2027)
5 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Application
    5.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Historic Market Review by Application (2016-2021)
        5.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
        5.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2016-2021)
        5.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Application (2016-2021)
    5.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Application (2022-2027)
        5.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Application (2022-2027)
        5.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Forecast by Application (2022-2027)

6 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
    6.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
        6.1.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
        6.1.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
    6.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
        6.2.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
        6.2.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
    6.3 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
        6.3.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2016-2021)
        6.3.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2022-2027)

7 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
    7.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
        7.1.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
        7.1.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
    7.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
        7.2.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
    7.3 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
        7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)

8 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
    8.1 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
        8.1.1 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
        8.1.2 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
    8.2 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
        8.2.1 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
        8.2.2 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
    8.3 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
        8.3.1 China 243 Sales Breakdown by Application (2016-2021)
        8.3.2 China 243 Sales Breakdown by Application (2022-2027)

9 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
    9.1 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
        9.1.1 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
        9.1.2 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
    9.2 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
        9.2.1 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
    9.3 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
    10.1 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
        10.1.1 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
        10.1.2 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
    10.2 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
        10.2.1 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures
    11.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
        11.1.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
        11.1.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
    11.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
        11.2.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
        11.2.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
    11.3 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
        11.3.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2016-2021)
        11.3.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Non-alcoholic Steatohepatitis (NASH) Biomarkers Business
    12.1 Biopredictive
        12.1.1 Biopredictive Corporation Information
        12.1.2 Biopredictive Business Overview
        12.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
        12.1.5 Biopredictive Recent Development
    12.2 Quest Diagnostics
        12.2.1 Quest Diagnostics Corporation Information
        12.2.2 Quest Diagnostics Business Overview
        12.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
        12.2.5 Quest Diagnostics Recent Development
    12.3 Exalenz Bioscience
        12.3.1 Exalenz Bioscience Corporation Information
        12.3.2 Exalenz Bioscience Business Overview
        12.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
        12.3.5 Exalenz Bioscience Recent Development
    12.4 GENFIT
        12.4.1 GENFIT Corporation Information
        12.4.2 GENFIT Business Overview
        12.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
        12.4.5 GENFIT Recent Development
    12.5 Siemens Healthineers
        12.5.1 Siemens Healthineers Corporation Information
        12.5.2 Siemens Healthineers Business Overview
        12.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
        12.5.5 Siemens Healthineers Recent Development
    12.6 ONE WAY LIVER
        12.6.1 ONE WAY LIVER Corporation Information
        12.6.2 ONE WAY LIVER Business Overview
        12.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
        12.6.5 ONE WAY LIVER Recent Development
    12.7 Prometheus Laboratories
        12.7.1 Prometheus Laboratories Corporation Information
        12.7.2 Prometheus Laboratories Business Overview
        12.7.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
        12.7.5 Prometheus Laboratories Recent Development
    12.8 Gilead Sciences
        12.8.1 Gilead Sciences Corporation Information
        12.8.2 Gilead Sciences Business Overview
        12.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
        12.8.5 Gilead Sciences Recent Development

13 Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Cost Analysis
    13.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
    13.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List
    14.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers

15 Market Dynamics
    15.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends
    15.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Drivers
    15.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges
    15.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Region (2016-2021)
    Table 5. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2016-2021)
    Table 6. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Region (2016-2021)
    Table 8. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Company (2016-2021)
    Table 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Company (2016-2021)
    Table 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers as of 2020)
    Table 17. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price (US$/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Sites and Area Served
    Table 19. Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Type (2016-2021)
    Table 22. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Type (2016-2021)
    Table 23. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2016-2021)
    Table 25. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Type (2022-2027)
    Table 26. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Type (2022-2027)
    Table 28. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2022-2027)
    Table 29. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2016-2021) 
    Table 30. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Application (2016-2021)
    Table 31. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2016-2021)
    Table 33. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2022-2027)
    Table 34. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Application (2022-2027)
    Table 35. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Application (2022-2027)
    Table 37. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2022-2027)
    Table 38. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
    Table 39. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
    Table 40. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
    Table 42. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
    Table 43. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
    Table 44. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
    Table 45. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
    Table 46. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
    Table 47. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
    Table 48. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
    Table 49. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
    Table 50. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
    Table 51. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
    Table 52. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
    Table 54. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
    Table 56. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
    Table 58. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
    Table 60. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
    Table 62. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
    Table 63. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
    Table 64. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
    Table 66. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
    Table 67. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
    Table 68. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
    Table 69. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
    Table 70. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
    Table 71. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
    Table 72. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
    Table 73. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
    Table 74. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
    Table 75. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
    Table 76. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
    Table 78. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
    Table 80. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
    Table 82. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
    Table 84. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
    Table 98. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Company (2016-2021)
    Table 99. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2016-2021)
    Table 100. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2016-2021)
    Table 102. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016-2021) & (K Units)
    Table 103. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
    Table 104. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2022-2027) & (K Units)
    Table 105. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2022-2027)
    Table 106. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2016-2021) & (K Units)
    Table 107. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
    Table 108. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2022-2027) & (K Units)
    Table 109. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022-2027)
    Table 110. Biopredictive Corporation Information
    Table 111. Biopredictive Description and Business Overview
    Table 112. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 113. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
    Table 114. Biopredictive Recent Development
    Table 115. Quest Diagnostics Corporation Information
    Table 116. Quest Diagnostics Description and Business Overview
    Table 117. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 118. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
    Table 119. Quest Diagnostics Recent Development
    Table 120. Exalenz Bioscience Corporation Information
    Table 121. Exalenz Bioscience Description and Business Overview
    Table 122. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 123. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
    Table 124. Exalenz Bioscience Recent Development
    Table 125. GENFIT Corporation Information
    Table 126. GENFIT Description and Business Overview
    Table 127. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 128. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
    Table 129. GENFIT Recent Development
    Table 130. Siemens Healthineers Corporation Information
    Table 131. Siemens Healthineers Description and Business Overview
    Table 132. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 133. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
    Table 134. Siemens Healthineers Recent Development
    Table 135. ONE WAY LIVER Corporation Information
    Table 136. ONE WAY LIVER Description and Business Overview
    Table 137. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 138. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
    Table 139. ONE WAY LIVER Recent Development
    Table 140. Prometheus Laboratories Corporation Information
    Table 141. Prometheus Laboratories Description and Business Overview
    Table 142. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 143. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
    Table 144. Prometheus Laboratories Recent Development
    Table 145. Gilead Sciences Corporation Information
    Table 146. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 147. Gilead Sciences Description and Business Overview
    Table 148. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
    Table 149. Gilead Sciences Recent Development
    Table 150. Production Base and Market Concentration Rate of Raw Material
    Table 151. Key Suppliers of Raw Materials
    Table 152. Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List
    Table 153. Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers List
    Table 154. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends
    Table 155. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers
    Table 156. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges
    Table 157. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Picture
    Figure 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2021 & 2027
    Figure 6. Hospitals Examples
    Figure 7. Diagnostic Centers Examples
    Figure 8. Others Examples
    Figure 9. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 11. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) Growth Rate (2016-2027)
    Figure 12. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Trends Growth Rate (2016-2027) (US$/Unit)
    Figure 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region: 2016 VS 2021
    Figure 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region: 2021 VS 2027
    Figure 15. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
    Figure 16. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) Growth Rate (2016-2027)
    Figure 17. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
    Figure 18. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (Million USD) Growth Rate (2016-2027)
    Figure 19. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
    Figure 20. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (Million USD) and Growth Rate (2016-2027)
    Figure 21. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
    Figure 22. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (Million USD) Growth Rate (2016-2027)
    Figure 25. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
    Figure 26. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (Million USD) Growth Rate (2016-2027)
    Figure 27. Global 5 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players Market Share by Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers: 2016 & 2020
    Figure 28. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 29. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Type (2016-2021)
    Figure 30. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate by Type in 2016 & 2020
    Figure 31. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Application (2016-2021)
    Figure 32. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate by Application in 2016 & 2020
    Figure 33. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
    Figure 34. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
    Figure 35. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
    Figure 36. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
    Figure 37. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
    Figure 38. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
    Figure 39. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
    Figure 40. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
    Figure 41. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
    Figure 42. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
    Figure 43. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2020
    Figure 44. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application in 2020
    Figure 45. Key Raw Materials Price Trend
    Figure 46. Manufacturing Cost Structure of Non-alcoholic Steatohepatitis (NASH) Biomarkers 
    Figure 47. Manufacturing Process Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
    Figure 48. Non-alcoholic Steatohepatitis (NASH) Biomarkers Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation 
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biopredictive
Quest Diagnostics
Exalenz Bioscience
GENFIT
Siemens Healthineers
ONE WAY LIVER
Prometheus Laboratories
Gilead Sciences
Frequently Asked Questions
Non-alcoholic Steatohepatitis (NASH) Biomarkers report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-alcoholic Steatohepatitis (NASH) Biomarkers report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-alcoholic Steatohepatitis (NASH) Biomarkers report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports